TrialArthritis research & therapy2019

Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age.

John Tesser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.